Inovio Pharmaceuticals announced  VGX-3100, its Phase 3 immunotherapy to treat cervical dysplasia, was selected for the "Best Therapeutic Vaccine" award at the World Vaccine Congress held in Washington, D.C. Each year, the Vaccine Industry Excellence (ViE) award...